Myriad Genetics (MYGN) Capital Expenditures Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 50.00% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 3.87% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -3.27% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -72.44% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -33.33% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 1.48% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -10.56% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 18.75% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 0.92% |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn | 1.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.89% |
| Dec 31, 2025 | 30.56% |
| Sep 30, 2025 | -20.00% |
| Jun 30, 2025 | -46.15% |
| Mar 31, 2025 | -20.90% |
| Dec 31, 2024 | -93.64% |
| Sep 30, 2024 | 109.80% |
| Jun 30, 2024 | -72.34% |
| Mar 31, 2024 | -71.49% |
| Dec 31, 2023 | 24.94% |
| Sep 30, 2023 | -174.62% |
| Jun 30, 2023 | 180.60% |
| Mar 31, 2023 | 273.02% |
| Dec 31, 2022 | 1,232.35% |
| Sep 30, 2022 | -533.33% |
| Jun 30, 2022 | 48.89% |
| Mar 31, 2022 | -11.27% |
| Dec 31, 2021 | -56.96% |
| Sep 30, 2021 | 100.00% |
| Jun 30, 2021 | -15.09% |